India and Italy are shaping an Indo-Mediterranean partnership focused on trade, AI, defence, clean energy and connectivity, with Narendra M...

Indian stock markets experienced a significant downturn on Thursday, with Sensex and Nifty both falling over 0.7%. This decline was driven ...

Donald Trump's proposed 100% tariffs on patented drugs from October 2025 are unlikely to immediately impact Indian pharma exports, which pr...

Sun Pharma, India's largest drug maker, said it expects its innovative products to garner $1.5 billion in sales in the next 3-4 years.

The statement further said that the alliance is working closely with the International generic and biosimilar medicines association, the WH...

Indian Pharmaceutical Alliance had noted that the industry annually receives around Rs 3300 to Rs 5500 crore in expired or damaged stock an...

Sun’s products are part of the long-listed and established prescription brands and includes Parlodel, Lamsil, Nitroderm and Lopressor.

Bar-coding of mono cartons, which hold primary packs of drugs, will enable them to be traced back to the source, the ministry of commerce s...

Indian Pharma Alliance, a grouping of top domestic drugmakers, in its latest submission has urged the USTR to consider submissions of many ...

Solicitor-General Ranjit Kumar’s opinion said the regulator had exceeded powers by cutting price of non-essential drugs.

The label is the lowest classification any country can find itself in on a US made rating scale for intellectual property protection.

Another official said the pharma department has taken up the issue with the ministry of health, which had set up the expert panel to list o...

India's drug regulator is working on a policy on how to respond to safety alerts by foreign regulator on medicines manufactured by Indian co

A government panel proposes a mechanism that will apply only to medicines bought through public procurement and health insurance companies.

In an interview with ET Now, Dilip G Shah, Secretary-General, Indian Pharmaceutical Alliance, gives his views on the drug pricing policy. E...

UK-BASED £14billion pharma, health and beauty retail major Alliance Boots is planning to make its entry in the Indian retail market.

UK-based £14billion pharma, health and beauty retail major Alliance Boots is planning to make its entry in the Indian retail market. The co...